Since NAFLD patients have reduced serum levels of adiponectin, the above described mechanisms represent an interesting link between NAFLD and cancer development at both gastrointestinal and extra-intestinal site. This evidence concerns the gene ADIPOQ and metabolic dysfunction-associated steatotic liver disease.